• Space

    Landmark COVID Research Grant awarded by the European Union - Research Team focused on finding solutions to real-world issues

    Learn More
  • Space

    Johnathan Summers interview with Richard Zwicky on Cannabis Radio to discuss how EXMceuticals is climbing towards 'The Green Peak'.

    Learn More
  • Space

    Biosciences company with expertise in cannabinoid

    Learn More
  • Space

    Research Team focused on finding solutions to real-world issues

    Learn More
  • Space

    We are targeting the medical and legal 200bn USD global cannabis market estimated for 2028

    Learn More

Biotech company that focuses on cannabis

EXMceuticals (“EXM”) is a bio-science company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become one of the world's suppliers of highest-grade cannabis ingredients. EXM is currently creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry.

EXMceuticals_icons_extract.png

Research Driven

Research-driven in cannabis extraction, distillation, purification and cannabinoid isolation with industry leading scientists

EXMceuticals_icons_organic.png

Innovation

Fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.

EXMceuticals_icons_medical.png

Medical

Focused on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry.

EXMceuticals_icons_scalable.png

Flexible Revenue Model

Our state-of-the-art testing lab is equipped to conduct all quality control testing for third parties. Processing Services to transform biomass or oil into high-grade extracts and white labelling services in the creation of custom extracts for specific product formulations.

Updates

News

Latest News

Access our latest news

lab-217041.jpg

Research and Development

EXMceuticals's fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery ...

Lab.jpeg

EXMceuticals obtains its research and development

EXMceuticals Portugal has obtained the authorization for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and ...

Exchange Price % Move
CSE:EXM
FSE:A2PAW2

Investor information

EXMceuticals Inc. Sets its Sights firmly on the estimated €200 Billion value of the combined European and US cannabis market in 2028 .

Our Portuguese extraction and refinery hub will process the raw materials from GMP certified suppliers in both Portugal and Internationally. Portugal will serve as the gateway to distribute pure ingredients across Europe and into North America & Asia.

Our Landmark BioBlockCOVID Project Research Grant accelerates our activities in our lab and keep our team focus on finding solutions to a real-world issue.

Learn more